Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (DOC) Q3 2026 Earnings Call Transcript

Can PEAK:AIO Buyout Give NetApp a Competitive Edge in AI-Scale Storage?

Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026

PEAK:AIO and Los Alamos National Laboratory Launch Lattice - Breaking Open the Metadata Bottleneck in Parallel File Systems

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

F45 Training Introduces F45 PEAK500: A New Era of Standardized Athletic Performance Testing

Cogent Biosciences to Initiate New Drug Application (NDA) Submission for Bezuclastinib Under Real-Time Oncology Review (RTOR)

Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)

Y Intercept Hong Kong Ltd Raises Stock Holdings in Healthpeak Properties, Inc. $DOC

Cullen Frost Bankers Inc. Increases Position in Healthpeak Properties, Inc. $DOC

Chicago Partners Investment Group LLC Invests $205,000 in Healthpeak Properties, Inc. $DOC

Healthpeak Properties, Inc. (DOC) Q3 2025 Earnings Call Transcript

Will Campbell's PEAK Savings Program Lift Margins by 2028?

Healthpeak Properties: Trading Near Decade Lows

Healthpeak Properties, Inc. (DOC) Q1 2025 Earnings Call Transcript

5 Monthly-Paying REITs To Sleep Well At Night

Healthpeak Properties, Inc. (DOC) Q4 2024 Earnings Call Transcript

HealthPeak Boosts Flexibility With $3B Revolving Credit Facility

HMS Networks has completed the acquisition of PEAK-System Technik